UPDATE: Allergan (AGN), TPG Said to Mull Bids for Valeant Pharma's (VRX) Eye-Surgery Assets - Bloomberg

November 18, 2016 10:27 AM EST

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
(Updated - November 18, 2016 10:30 AM EST)

Allergan (NYSE: AGN) and TPG are among potential suitors for Valeant Pharma's (NYSE: VRX) eye-surgery assets, according to Bloomberg. The assets also attracted interest from Germany's Carl Zeiss Meditec AG and other private equity firms in Asia.

The assets could fetch $2 billion.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions, Private Equity, Rumors, Trader Talk

Add Your Comment